[Local immunotherapy prevention of recurrent respiratory infections in children].
A group of 20 children aged between 2.5 and 10 years with recurrent respiratory infections (greater than 6/year) was treated with local immunotherapy (Biomunil spray) for a six-month period (October-March 1988/89). Referring to the same period on last year, a statistically significant decrease of upper respiratory infections was observed (p less than 0.001) as well as an increase of S-IgA rate (p less than 0.001) and less of serum IgA and IgG. The compliance and the tolerance of the drug was good.
Venturi
M C
MC
Clinica Pediatrica I, Università degli Studi di Milano.
Biolchini
A
A
Bardare
M
M
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects; D000281:Administration, Intranasal; D001685:Biological Factors / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D012270:Ribosomes / Q000276:immunology
D000276:Adjuvants, Immunologic; D001685:Biological Factors
Prevenzione con immunoterapia locale delle infezioni respiratorie ricorrenti nel bambino.